Used in pharmaceutical research as a key intermediate in the synthesis of histamine H3 receptor antagonists. It plays a role in developing compounds targeting neurological disorders such as Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), and epilepsy due to its ability to modulate neurotransmitter release. The compound's structure allows for selective binding and improved metabolic stability in drug candidates. Also explored in the development of anti-inflammatory agents and in medicinal chemistry for optimizing lead compounds with enhanced bioavailability.